InsiderClue
Insiders · Profile

Gregory Kathryn

SVP, Chief Business Officer at Rein Therapeutics. Filing since 13 Aug 2019. CIK 0001768530

Company
Date
Role
Action
Shares
Amount
Of holding
RNTX Rein Therapeutics, Inc.
13 Aug 2019
SVP, Chief Business Officer
Bought
45,000
$29.03K
opened
1 decision on file.